Welcome to our dedicated page for Kopin SEC filings (Ticker: KOPN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kopin Corporation (NASDAQ: KOPN) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including registration statements, current reports and financial reports filed with the U.S. Securities and Exchange Commission. Kopin describes itself in these documents as a Delaware corporation, incorporated in 1984 and headquartered in Westborough, Massachusetts, focused on high-performance microdisplays and application-specific optical solutions for defense, enterprise, industrial, consumer and medical products.
Among the key filings, Kopin has submitted Form S-1 and S-1/A registration statements related to the resale of common stock issued in a private placement. These documents outline the terms of a PIPE financing, the number of shares registered for resale, the Nasdaq Capital Market listing under the symbol KOPN, and risk factor and business overview sections that describe its microdisplay portfolio, Application Specific Optical Solutions (ASOS), and global defense and industrial markets.
The company also files multiple Form 8-K current reports to disclose material events. Recent 8-Ks describe a $15 million strategic investment from Theon International Plc, including the issuance of Series A Convertible Preferred Stock and a 49% interest in Kopin Europe Ltd., agreements to co-develop military-grade displays and color MicroLED products, a $41 million private placement of common stock, litigation-related financing arrangements, and leadership and compensation changes. Another 8-K incorporates by reference quarterly financial results, which detail revenue by category (defense, industrial/enterprise, medical, research and development, and license and royalties), expenses and net income or loss.
On Stock Titan, these filings are updated in near real time from EDGAR and can be paired with AI-powered summaries that explain the significance of each document. Users can quickly understand how a new S-1, 8-K or other filing affects Kopin’s capital structure, strategic partnerships, litigation exposure or operating performance. Investors can also use the filings page to monitor developments related to preferred stock terms, registration rights agreements, licensing and collaboration agreements, and other contracts referenced in Kopin’s disclosures.
Kopin Corp (KOPN) director David J. Nieuwsma received a grant of 64,500 restricted stock shares on June 26, 2025. The shares were awarded at $0.00 per share under the company's 2020 Equity Incentive Plan.
Key details of the transaction:
- The restricted stock will vest on June 26, 2026
- Following the transaction, Nieuwsma now beneficially owns 193,500 shares directly
- The Form 4 was filed by John J. Concannon as attorney-in-fact on June 27, 2025
This equity grant appears to be part of the company's director compensation program, representing a significant increase in Nieuwsma's stake in the company. The one-year vesting period aligns the director's interests with long-term shareholder value.